Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open-label, Platform Study for Long-term Follow-up of Participants Using Study Intervention in Pulmonary Hypertension Parent Studies

NCT05179876 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT05179876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05179876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open-label, Platform Study for Long-term Follow-up of Participants Using Study Intervention in Pulmonary Hypertension Parent Studies
Lead sponsor
Actelion
Phase
Phase 3
Overall status
Recruiting
Start date
May 4, 2022
Completion date
September 30, 2030
Enrollment
280 (estimated)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, pulmonary